What Researchers Did
Researchers retrospectively investigated the effect of hyperbaric oxygen therapy (HBOT) on myocardial perfusion in 115 patients with coronary artery disease who had received drug-eluting stents, comparing an HBOT group (n=55) to a control group (n=60).
What They Found
The HBOT group showed a significantly higher improvement rate of impaired myocardial sub-segments compared to the control group (P<0.05). Additionally, endothelin-1 and high sensitivity C-reactive protein levels significantly decreased, while nitric oxide levels significantly increased in the HBOT group (P<0.05).
What This Means for Canadian Patients
For Canadian patients who have received drug-eluting stents, hyperbaric oxygen therapy may offer a way to improve blood flow to the heart muscle. This could potentially lead to better heart function and reduced inflammation after stent implantation.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
As a retrospective study, this research is subject to potential biases and confounding factors that could influence the results.